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Spinal epidural lipomatosis is a rare and complex disor-
der that can present with progressive neurological deficits.
Hypertrophy of adipose tissue located in the spinal epidu-
ral space is most commonly associated with long-term
steroid use but can be observed in patients with a number
of other conditions. As the adipose tissue enlarges, it
encroaches on the spinal canal and compresses the neural
elements. We have reviewed the literature on SEL and
summarize current trends in the management of this con-
dition.
CAUSES OF SEL
Most reported cases of SEL are associated with long-
term use of exogenous steroids, but a number of
non–steroid-related cases have been reported, including
some associated with Cushing disease, Cushing syn-
drome, hypothyroidism,17 pituitary prolactinoma,5 and
obesity.2,8,13 A number of idiopathic cases have also been
reported.1,3,9,11,18 The disorder is thought to be part of the
spectrum of abnormal adipose deposition that is observed
in patients with Cushing syndrome. It appears to occur
more commonly in men than women, with 75% of report-
ed cases involving male patients.13,14,18 The mean age of
patients with SEL who have been described in the litera-
ture is 43 years, but the disorder tends to occur at a
younger age in male patients.13,14,18 The youngest reported
case was in a 6-year-old boy who was receiving high-dose
steroid therapy.12
Among the series that have been reported, approxi-
mately 75% of cases have been associated with exogenous
steroid use.18 Dosages and duration of steroid use vary
widely in patients in whom this condition develops. In
most cases, moderate-to-high steroid dosages have been
received for years before the development of symptoms.
The mean daily doses of prednisone in SEL series in the
literature have ranged from 30 to 100 mg and the mean
duration of steroid use before the development of symp-
toms have ranged from 5 to 11 years.4 Nevertheless, this
condition has developed in some patients who have used
steroids for months and at relatively low dosages.4,19 There
have been reports of SEL associated with epidural steroid
injections and even inhaled steroids, but long-term use of
oral steroids is by far the most common association.10,14,15
FINDINGS OF SEL
Clinical Findings
Back pain is the most frequently reported symptom
associated with SEL and often presents long before the
other symptoms. Lower-extremity weakness is also a
common complaint and appears to be slowly progressive
in most cases. Sensory changes with numbness, paresthe-
sias, or radicular symptoms are also common. Bowel and
bladder incontinence are reported, but appear to be rare
complaints. On physical examination, lower-extremity
weakness is the most common finding with decreased pin-
prick sensation and altered reflexes also frequently occur-
ring.4,13,14
Obviously, the symptoms are somewhat dependent
on the level of canal compromise (spinal cord, conus
medullaris, or cauda equina), with thoracic levels produc-
ing myelopathic effects and lumbar levels having radicu-
lar effects. A majority of these patients present with tho-
racic epidural lipomatosis and, therefore, progressive
myelopathy is a more common presentation than radicular
complaints.
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Abbreviations used in this paper: CT = computerized tomogra-
phy; MR = magnetic resonance; SEL = spinal epidural lipomatosis.
Imaging Findings
Although SEL cannot be diagnosed on plain x-ray
films, these studies can help rule out more sinister causes
of back pain such as degenerative disease and tumors.
During the pre-MR imaging era, diagnosis was based on
findings on myelograms and CT scans. Myelography re-
veals an obstruction to the contrast dye at the level of the
canal compression, and the filling pattern is helpful in
determining whether the obstruction is intradural or ex-
tradural. An hourglass pattern of contrast obstruction is
usually associated with an epidural mass such as SEL.
Axial CT scans are used to help differentiate the cause
of the compression based on the density of the tissue in
the epidural space. Adipose tissue has a density ranging
between ✁80 and ✁120 HU on CT scans; this differenti-
ates it from most other tissues in the area.14,16
Magnetic resonance imaging has replaced CT scanning
as the study of choice for the diagnosis of SEL. Canal
compression with obliteration of the cerebrospinal fluid
spaces can be appreciated on axial and sagittal MR im-
ages, and a high-signal intensity on T1-weighted images
and an intermediate signal on T2-weighted images are
characteristic of adipose tissue. Epidural adipose tissue
that has a thickness greater than 7 mm has been reported
to be the diagnostic criterion for SEL (Fig. 1).8,13 Spinal
epidural lipomatosis should be differentiated from encap-
sulated spinal lipomas, which can also cause epidural spi-
nal compression.
Thoracic involvement is most common, with between
58 and 61% of cases involving the thoracic cord. Lumbar
involvement is found in 39 to 42% of cases and cervi-
cal SEL has never been reported.4,18 Some clinicians have
suggested that female patients are more likely to have
lumbar SEL.14 Often there is an asymmetrical deposition
of adipose tissue in the epidural space with greater adipose
hypertrophy in the dorsal and lateral regions of this
space.18
Although MR imaging is the study of choice for most
cases, clinicians should familiarize themselves with the
myelography and CT characteristics of SEL, because a
portion of these patients will be unable to undergo MR
imaging because of body habitus and other factors.
TREATMENT OF SEL
Treatment options include conservative therapy and
surgical intervention. Given the limited number of cases,
clinical trials have not been performed to compare out-
comes of conservative and surgical management.
Conservative therapy, including weaning of patients from
steroids and weight loss, has been successful in a number
of cases.2,4,13,18 Nevertheless, many patients receive steroid
medications for other chronic illnesses and may not toler-
ate weaning from the therapy. Weight loss has been report-
ed to be very successful in patients with SEL in whom
obesity is thought to be the cause of the adipose hypertro-
phy.2,11,13 Patients not receiving steroids should undergo an
endocrinological evaluation for possible endogenous cor-
ticosteroid overproduction. In most cases, treatment of
endogenous corticosteroid overproduction should be un-
dertaken before spinal decompression is considered.
Surgical intervention, with decompressive laminecto-
my and resection of epidural adipose tissue, has report-
edly been successful in a large percentage of patients. It
appears that a majority of these patients experience im-
provement or resolution of their neurological symptoms
after surgical intervention.13 Patients with pathological
conditions in the lumbar (cauda equina) region tend to
make a better recovery following surgical decompression
than patients with pathological conditions in the thoracic
region.14 Preoperative steroid doses are also reported to
influence neurological recovery, with patients receiving
lower doses of steroids having a better chance for recov-
ery.14 It also appears that patients with idiopathic SEL tend
to have a better prognosis, with most attaining complete
recovery after surgical decompression.7,9,11,13 Some pa-
tients have been known to require multiple surgeries
because of reaccumulation of epidural fat, but this appears
to be very rare.6
Although the surgical procedure itself is low risk, the
postoperative management of these patients’ concomitant
medical problems and comorbidities can be fraught with
complications and morbidity. Fessler and colleagues4
reported a 22% mortality rate in these patients within 1
year after surgical decompression. They recommend
attempting conservative treatment for patients without
significant cord compression. Given that this process is a
slow gradual compression of the neural structures, there is
no evidence to suggest that rapid decompression will
result in improved recovery. We favor a more conservative
strategy, especially in patients with significant comorbidi-
ties, and reserve surgical decompression for patients in
whom conservative measures fail.
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Fig. 1. Sagittal T1-weighted MR image of the thoracic spine of
a 36-year-old man who engaged in long-term steroid usage. This
image demonstrates hypertrophy of adipose tissue located posteri-
or to T5–L2. Compression fractures are also noted.
CONCLUSIONS
Spinal epidural lipomatosis is most commonly associat-
ed with long-term use of exogenous steroids, but can be
seen with a number of other conditions. Conservative
treatment, with either weight loss or weaning from
steroids, can successfully reduce epidural adipose tissue
leading to an improvement in symptoms. Decompressive
laminectomy with resection of epidural adipose tissue is
also very successful at improving neurological symptoms.
Given the significant comorbidities in many of these
patients, we would recommend reserving surgical inter-
vention for patients in whom conservative treatment fails.
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